Incidence and outcome of metabolic disarrangements consistent with citrate accumulation in critically ill patients undergoing continuous venovenous hemodialysis with regional citrate anticoagulation

2012, KDIGO AKI Work Group: KDIGO clinical practice guideline for acute kidney injury, Kidney Int Suppl, 2, 1

Wu, 2012, Regional citrate versus heparin anticoagulation for continuous renal replacement therapy: a meta-analysis of randomized controlled trials, Am J Kidney Dis, 59, 810, 10.1053/j.ajkd.2011.11.030

Zhang, 2012, Efficacy and safety of regional citrate anticoagulation in critically ill patients undergoing continuous renal replacement therapy, Intensive Care Med, 38, 20, 10.1007/s00134-011-2438-3

Joannidis, 2007, Clinical review: patency of the circuit in continuous renal replacement therapy, Crit Care, 11, 218, 10.1186/cc5937

Mariano, 2011, Citrate anticoagulation for continuous renal replacement therapy in critically ill patients: success and limits, Int J Nephrol, 2011, 748320, 10.4061/2011/748320

Faybik, 2011, Regional citrate anticoagulation in patients with liver failure supported by a molecular adsorbent recirculating system, Crit Care Med, 39, 273, 10.1097/CCM.0b013e3181fee8a4

Slowinski, 2011, Multicenter prospective observational study on safety and efficacy of regional citrate anticoagulation in CVVHD in the presence of liver failure: the Liver Citrate Anticoagulation Threshold Study (L-CAT), Crit Care, 15, 127, 10.1186/cc9547

Oudemans-van Straaten, 2011, Clinical review: anticoagulation for continuous renal replacement therapy—heparin or citrate?, Crit Care, 15, 202, 10.1186/cc9358

Meier-Kriesche, 2001, Increased total to ionized calcium ratio during continuous venovenous hemodialysis with regional citrate anticoagulation, Crit Care Med, 29, 748, 10.1097/00003246-200104000-00010

Oudemans-van Straaten, 2010, Citrate anticoagulation for continuous renal replacement therapy in the critically ill, Blood Purif, 29, 191, 10.1159/000245646

Morgera, 2009, A safe citrate anticoagulation protocol with variable treatment efficacy and excellent control of the acid-base status, Crit Care Med, 37, 2018, 10.1097/CCM.0b013e3181a00a92

Hetzel, 2006, Citrate plasma levels in patients under regional anticoagulation in continuous venovenous hemofiltration, Am J Kidney Dis, 48, 806, 10.1053/j.ajkd.2006.07.016

Meier-Kriesche, 1999, Unexpected severe hypocalcemia during continuous venovenous hemodialysis with regional citrate anticoagulation, Am J Kidney Dis, 33, e8, 10.1016/S0272-6386(99)70249-0

Kramer, 2003, Citrate pharmacokinetics and metabolism in cirrhotic and noncirrhotic critically ill patients, Crit Care Med, 31, 2450, 10.1097/01.CCM.0000084871.76568.E6

Kutsogiannis, 2005, Regional citrate versus systemic heparin anticoagulation for continuous renal replacement in critically ill patients, Kidney Int, 67, 2361, 10.1111/j.1523-1755.2005.00342.x

Oudemans-van Straaten, 2009, Citrate anticoagulation for continuous venovenous hemofiltration, Crit Care Med, 37, 545, 10.1097/CCM.0b013e3181953c5e

Hetzel, 2011, Regional citrate versus systemic heparin for anticoagulation in critically ill patients on continuous venovenous haemofiltration: a prospective randomized multicentre trial, Nephrol Dial Transplant, 26, 232, 10.1093/ndt/gfq575

Mariano, 2010, Normal citratemia and metabolic tolerance of citrate anticoagulation for hemodiafiltration in severe septic shock burn patients, Intensive Care Med, 36, 1735, 10.1007/s00134-010-1909-2

Kalb, 2013, Regional citrate anticoagulation for high volume continuous venovenous hemodialysis in surgical patients with high bleeding risk, Ther Apher Dial, 17, 202, 10.1111/j.1744-9987.2012.01101.x

Morabito, 2012, Regional citrate anticoagulation in cardiac surgery patients at high risk of bleeding: a continuous veno-venous hemofiltration protocol with a low concentration citrate solution, Crit Care, 16, R111, 10.1186/cc11403

Link, 2012, Total-to-ionized calcium ratio predicts mortality in continuous renal replacement therapy with citrate anticoagulation in critically ill patients, Crit Care, 16, R97, 10.1186/cc11363

Piednoir, 2012, Heparin-induced thrombocytopenia after cardiac surgery: an observational study of 1,722 patients, J Cardiothorac Vasc Anesth, 26, 585, 10.1053/j.jvca.2011.11.009

Spencer, 2000, Heparin-induced thrombocytopenia: patient profiles and clinical manifestations, J Thromb Thrombolysis, 10, 21, 10.1023/A:1027325002276

Bakker, 2006, Detection of citrate overdose in critically ill patients on citrate-anticoagulated venovenous haemofiltration: use of ionised and total/ionised calcium, Clin Chem Lab Med, 44, 962, 10.1515/CCLM.2006.164

Moseley, 2004, Sepsis and cholestasis, Clin Liver Dis, 8, 83, 10.1016/S1089-3261(03)00134-X

O'Grady, 1989, Early indicators of prognosis in fulminant hepatic failure, Gastroenterology, 97, 439, 10.1016/0016-5085(89)90081-4

Chadha, 2002, Citrate clearance in children receiving continuous venovenous renal replacement therapy, Pediatr Nephrol, 17, 819, 10.1007/s00467-002-0963-6

Swartz, 2004, Improving the delivery of continuous renal replacement therapy using regional citrate anticoagulation, Clin Nephrol, 61, 134, 10.5414/CNP61134

James, 2004, Dose-response relationship between plasma ionized calcium concentration and thrombelastography, J Cardiothorac Vasc Anesth, 18, 581, 10.1053/j.jvca.2004.07.016

Calatzis, 2001, Citrate anticoagulation for extracorporeal circuits: effects on whole blood coagulation activation and clot formation, Nephron, 89, 233, 10.1159/000046075